Published in Expert Rev Anticancer Ther on September 05, 2014
Paucity of HPV-Related Head and Neck Cancers (HNC) in Nigeria. PLoS One (2016) 0.81
Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck Cancer. Viruses (2015) 0.79
Alcohol and Tobacco Increases Risk of High Risk HPV Infection in Head and Neck Cancer Patients: Study from North-East Region of India. PLoS One (2015) 0.78
High Risk Alpha Papillomavirus Oncogenes Impair the Homologous Recombination Pathway. J Virol (2017) 0.75
Immunotherapy against cancer-related viruses. Cell Res (2016) 0.75
Human papillomavirus in head and neck cancer in India: Current status and consensus recommendations. South Asian J Cancer (2017) 0.75
The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma. Int J Clin Oncol (2016) 0.75
Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med (2010) 22.74
The mutational landscape of head and neck squamous cell carcinoma. Science (2011) 16.88
Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med (2007) 16.39
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst (2008) 12.77
Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol (2011) 12.10
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science (2011) 11.12
Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst (2013) 8.75
Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst (2008) 8.70
Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol (2008) 7.97
The cervical cancer epidemic that screening has prevented in the UK. Lancet (2004) 7.72
HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol (2010) 6.53
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med (2001) 6.33
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst (2003) 6.28
Prevalence of oral HPV infection in the United States, 2009-2010. JAMA (2012) 6.02
Sexual behavior and selected health measures: men and women 15-44 years of age, United States, 2002. Adv Data (2005) 5.62
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol (2008) 5.46
Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst (2005) 5.29
Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis (2009) 5.24
Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep (2011) 4.68
Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis (2006) 4.67
Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. J Clin Oncol (2006) 4.66
Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis (2010) 4.42
Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst (1998) 4.42
Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol (2010) 4.39
FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep (2010) 4.34
Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer (2007) 4.20
Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer (2005) 3.79
Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila) (2009) 3.70
Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst (2004) 3.67
Sexual behavior in the United States 1930-1990: trends and methodological problems. Sex Transm Dis (1995) 3.61
Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol (2008) 3.55
p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol (2010) 3.37
Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis (2000) 3.36
Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer (2005) 3.27
Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet (2013) 3.25
Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis (2004) 3.04
Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol (2013) 3.00
Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. J Infect Dis (2011) 2.88
Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol (2013) 2.87
National and state vaccination coverage among adolescents aged 13-17 years--United States, 2012. MMWR Morb Mortal Wkly Rep (2013) 2.67
Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer (2004) 2.59
Oral versus vaginal sex among adolescents: perceptions, attitudes, and behavior. Pediatrics (2005) 2.54
Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res (2009) 2.51
Oral sex and the transmission of viral STIs. Sex Transm Infect (1998) 2.50
A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prev Res (Phila) (2009) 2.42
Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer--systematic review and meta-analysis of trends by time and region. Head Neck (2012) 2.40
Genital human papillomavirus infection in men. Lancet Infect Dis (2006) 2.39
Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer (2007) 2.37
Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res (2005) 2.32
Age-Specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study. J Infect Dis (2004) 2.21
Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads. Clin Infect Dis (2005) 2.20
Changes in sexual behaviours: from secular trends to public health policies. AIDS (2010) 2.17
Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer (2000) 2.17
Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis (2010) 2.10
Acceptability of human papillomavirus vaccine for males: a review of the literature. J Adolesc Health (2010) 2.05
Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One (2013) 2.03
Adolescent oral sex, peer popularity, and perceptions of best friends' sexual behavior. J Pediatr Psychol (2003) 1.96
End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age. Br J Cancer (2011) 1.96
Transmission of human papillomavirus in heterosexual couples. Emerg Infect Dis (2008) 1.93
Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Prev Med (2011) 1.89
Prevalence of human papillomavirus in the oral cavity/oropharynx in a large population of children and adolescents. Pediatr Infect Dis J (2007) 1.88
Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma. Clin Cancer Res (2008) 1.85
I wanna hold your hand: the progression of social, romantic and sexual events in adolescent relationships. Perspect Sex Reprod Health (2007) 1.82
Prevalence and correlates of heterosexual anal and oral sex in adolescents and adults in the United States. J Infect Dis (2007) 1.78
Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg (2001) 1.71
Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol (2009) 1.70
Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiol Biomarkers Prev (2011) 1.68
Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis. Vaccine (2012) 1.68
Oral sex and transmission of non-viral STIs. Sex Transm Infect (1998) 1.66
Persistent human papillomavirus infection is associated with a generalized decrease in immune responsiveness in older women. Cancer Res (2006) 1.59
Coital and non-coital sexual behaviors of white and black adolescents. Am J Public Health (1985) 1.57
Predictors of early initiation of vaginal and oral sex among urban young adults in Baltimore, Maryland. Arch Sex Behav (2006) 1.52
Trends in premarital sex in the United States, 1954-2003. Public Health Rep (2007) 1.51
Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact. BJOG (2004) 1.51
The prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18-30 years. Sex Transm Dis (2012) 1.51
Rates and determinants of oral human papillomavirus infection in young men. Sex Transm Dis (2012) 1.48
Epidemiology of mucosal human papillomavirus infection and associated diseases. Public Health Genomics (2009) 1.48
Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women. J Clin Microbiol (2006) 1.46
Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer. Int J Cancer (2005) 1.45
The psychosocial impact of human papillomavirus infection: implications for health care providers. Int J STD AIDS (1996) 1.42
Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands. Eur J Cancer Prev (2000) 1.42
Natural history of oral papillomavirus infections in spouses: a prospective Finnish HPV Family Study. J Clin Virol (2005) 1.39
Natural history of anal vs oral HPV infection in HIV-infected men and women. J Infect Dis (2013) 1.37
Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk population. J Clin Microbiol (2004) 1.34
High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding. Obstet Gynecol (2010) 1.31
Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women. Cancer Res (2012) 1.31
Clinician's guide to human papillomavirus immunology: knowns and unknowns. Lancet Infect Dis (2009) 1.29
Oral human papillomavirus in men having sex with men: risk-factors and sampling. PLoS One (2012) 1.28
Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations. Cancer Prev Res (Phila) (2011) 1.27
Meta-analysis of human papillomavirus infection concordance. Cancer Epidemiol Biomarkers Prev (2010) 1.25
Role of human papillomavirus in non-oropharyngeal head and neck cancers. Oral Oncol (2013) 1.24
Stress, immunity, and cervical cancer: biobehavioral outcomes of a randomized clinical trial [corrected]. Clin Cancer Res (2008) 1.23
Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: a longitudinal cohort study among men who have sex with men. BMC Infect Dis (2011) 1.23
Natural history of human papillomavirus infections involving anal, penile, and oral sites among HIV-positive men. Sex Transm Dis (2013) 1.20
Differences in oral sexual behaviors by gender, age, and race explain observed differences in prevalence of oral human papillomavirus infection. PLoS One (2014) 1.20
The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas. Oral Oncol (2013) 1.17
Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites. Head Neck (2010) 1.16
Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partners. J Clin Oncol (2014) 1.16
Oral human papillomavirus infection in HIV-negative and HIV-infected MSM. AIDS (2013) 1.13
Smoking, alcohol, diet, dentition and sexual practices in the epidemiology of oral cancer in Poland. Eur J Cancer Prev (2003) 1.10
Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med (2007) 16.39
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science (2011) 11.12
Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer (2007) 2.37
Integrated, genome-wide screening for hypomethylated oncogenes in salivary gland adenoid cystic carcinoma. Clin Cancer Res (2011) 1.09
Long-term prognosis and risk factors among patients with HPV-associated oropharyngeal squamous cell carcinoma. Cancer (2013) 0.94
Elective versus Therapeutic Neck Dissection in Oral Cancer. N Engl J Med (2015) 0.92
Transoral robotic surgery experience in 44 cases. J Laparoendosc Adv Surg Tech A (2013) 0.89
The prevalence, diagnosis, and management of voice disorders in a National Ambulatory Medical Care Survey (NAMCS) cohort. Laryngoscope (2011) 0.84
Distinct epidemiologic characteristics of oral tongue cancer patients. Otolaryngol Head Neck Surg (2013) 0.83
Neck dissection through a facelift incision. Laryngoscope (2012) 0.80
Selective versus comprehensive neck dissection after chemoradiation for advanced oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg (2009) 0.80
The Effect of tumor subsite on short-term outcomes and costs of care after oral cancer surgery. Laryngoscope (2013) 0.78
An electrophysiologic model for functional assessment of effects of neurotrophic factors on facial nerve reinnervation. Arch Facial Plast Surg (2005) 0.77
The effect of amifostine on submandibular gland histology after radiation. Int J Otolaryngol (2012) 0.77
A novel step in the anterolateral thigh free flap harvest. Otolaryngol Head Neck Surg (2010) 0.75
Race Is Associated With Sexual Behaviors and Modifies the Effect of Age on Human Papillomavirus Serostatus Among Perimenopausal Women. Sex Transm Dis (2016) 0.75
Implications of the New Face of Head and Neck Cancer. Oncology (Williston Park) (2015) 0.75